BRPI0512921A - processo para tratamento e profilaxia de ms - Google Patents

processo para tratamento e profilaxia de ms

Info

Publication number
BRPI0512921A
BRPI0512921A BRPI0512921-4A BRPI0512921A BRPI0512921A BR PI0512921 A BRPI0512921 A BR PI0512921A BR PI0512921 A BRPI0512921 A BR PI0512921A BR PI0512921 A BRPI0512921 A BR PI0512921A
Authority
BR
Brazil
Prior art keywords
prophylaxis
treatment
multiple sclerosis
processes
new
Prior art date
Application number
BRPI0512921-4A
Other languages
English (en)
Inventor
Per Moestrup Jensen
Original Assignee
Den Kgl Veterinaer Og Landboho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Den Kgl Veterinaer Og Landboho filed Critical Den Kgl Veterinaer Og Landboho
Publication of BRPI0512921A publication Critical patent/BRPI0512921A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCESSO PARA TRATAMENTO E PROFILAXIA DE MS. A presente invenção fornece novas terapias e novos processos profiláticos para esclerose múltipla. São também fornecidos novos processos para diagnóstico. A invenção baseia-se na descoberta de que a esclerose múltipla é mais provavelmente causada pela infecção crónica com um microorganismo que possui reação cruzada imunologicamente com a espiroqueta Leptospira interrogans, que normalmente infecta o rato marrom.
BRPI0512921-4A 2004-07-01 2005-06-29 processo para tratamento e profilaxia de ms BRPI0512921A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401042 2004-07-01
PCT/DK2005/000444 WO2006002631A1 (en) 2004-07-01 2005-06-29 Method for multiple sclerosis treatment and prophylaxis by treatment of leptospira infection

Publications (1)

Publication Number Publication Date
BRPI0512921A true BRPI0512921A (pt) 2008-04-22

Family

ID=34956480

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512921-4A BRPI0512921A (pt) 2004-07-01 2005-06-29 processo para tratamento e profilaxia de ms

Country Status (12)

Country Link
US (1) US20080193440A1 (pt)
EP (1) EP1778280A1 (pt)
JP (1) JP2008505130A (pt)
KR (1) KR20070046096A (pt)
CN (1) CN101010098A (pt)
AU (1) AU2005259726A1 (pt)
BR (1) BRPI0512921A (pt)
CA (1) CA2579779A1 (pt)
EA (1) EA200700263A1 (pt)
IL (1) IL180367A0 (pt)
NO (1) NO20070577L (pt)
WO (1) WO2006002631A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1920781B1 (en) * 2006-11-10 2015-03-04 Glycotope GmbH Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors
EP2353004B1 (en) 2008-11-12 2018-01-03 Yeda Research and Development Co. Ltd. Diagnosis of multiple sclerosis
NZ577731A (en) * 2009-06-16 2010-08-27 Innate Therapeutics Ltd Compositions and methods for treatment of multiple sclerosis
CN101874898A (zh) * 2010-06-21 2010-11-03 严杰 预防不同血清群问号钩端螺旋体感染的通用型三价基因重组疫苗及其制备方法
WO2017058923A1 (en) 2015-09-28 2017-04-06 East Carolina University Aluminum based adjuvants for tolerogenic vaccination
EP4380608A1 (en) * 2021-08-06 2024-06-12 Yale University Leptospiral virulence modulating proteins and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643754A (en) * 1994-05-25 1997-07-01 The Regents Of The University Of California Nucleic acids encoding a leptospira outer membrane protein
US6140083A (en) * 1998-07-23 2000-10-31 The Regents Of The University Of California Leptospiral outer membrane protein, LipL46
EP2447278B1 (en) * 2002-10-10 2015-04-08 Cornell Research Foundation, Inc. Novel immunogenic proteins of Leptospira

Also Published As

Publication number Publication date
EP1778280A1 (en) 2007-05-02
AU2005259726A1 (en) 2006-01-12
CA2579779A1 (en) 2006-01-12
WO2006002631A1 (en) 2006-01-12
EA200700263A1 (ru) 2007-06-29
KR20070046096A (ko) 2007-05-02
NO20070577L (no) 2007-03-30
JP2008505130A (ja) 2008-02-21
US20080193440A1 (en) 2008-08-14
CN101010098A (zh) 2007-08-01
IL180367A0 (en) 2007-06-03

Similar Documents

Publication Publication Date Title
BRPI0512921A (pt) processo para tratamento e profilaxia de ms
NO20064935L (no) Fremgangsmate for fremstilling av oksykodonhydroklorid som har mindre enn 25 ppm 14-hydroksykodeioner
BRPI0720569B8 (pt) compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária
BR112013027171A2 (pt) trocador de calor e método para sua produção
BR112013032711A2 (pt) composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase
MX2009009207A (es) Metodos y composiciones para normalizar las secreciones de glandulas meibomianas.
BRPI0503785A (pt) sistema eletrÈnico de permuta de dados
MX2009001342A (es) Composiciones y metodos para el tratamiento de proctosigmoiditis por radiacion.
BRPI0612309B8 (pt) compostos e composições farmacêuticas antivirais
NO20074238L (no) Fiksert dosering av HER-antistoffer
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
MX2010006096A (es) Anticuerpo anti-nr10 y su uso.
BRPI0413582B8 (pt) compostos, composições e métodos para inibir a atividade de proteasome
BRPI0509903A (pt) uso de compostos peptìdicos para profilaxia e tratamento da cefaléia crÈnica
NO20060242L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin
BR112013003847A2 (pt) métodos de tratar a deterioração cognitiva moderada (mci) e os distúrbios relacionados
NO20080462L (no) Krystallformer av astaxantin
BR112012024359A2 (pt) contorção de um aparelho eletrônico
NO20035571L (no) N-formyl hydroksylaminforbindelser som PDF-inhibitorer
BRPI0414177A (pt) inibidores de girase
CL2021003244A1 (es) Tratamientos de angioedema hereditario
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
BR112018013187A2 (pt) método e aparelho para inibir a interrupção de conteúdo sendo consumido por um usuário
BR0112497A (pt) Antìgenos de streptococcus pyogenes
TR201820975A2 (tr) İbuprofen, Psödoefedrin ve Erdostein İçeren Uzatılmış Salım Sağlayan Farmasötik Kompozisyon

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]